FDA approved Pfizer’s migraine nasal spra

The Food and Drug Administration has approved Pfizer’s migraine nasal spray as an instant pain relief for people suffering from it.

Fox News, Pfizer launched the medication named Zavzpret, a medication that blocks CGRPs, a protein released in the brain that triggers migraines.

It is the first calcitonin gene-released peptide receptor antagonist nasal spray to be approved by the FDA.

It was approved after two randomized, double-blind, placebo-controlled studies, as told by Pfizer in a statement.